Neurotransmitter release during deep brain stimulation

2Citations
Citations of this article
10Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Deep brain stimulation (DBS) is currently under investigation for treatment of a number of psychiatric indications, including obsessive–compulsive disorder, treatment-resistant depression, and Tourette’s syndrome. Despite its clinical efficacy, the mechanism of action of DBS is incompletely understood. Contrary to the previously proposed mechanism of local inhibition of neural elements at the stimulation site, recent studies have argued that DBS may also cause excitation of efferent target neurons and subsequent changes in neural network activity and neurotransmitter release at various nodes within the neural network. However, the necessary link between symptom change and a corresponding change in neurotransmitters has yet to be firmly established and will be essential to advance our understanding of psychiatric neurobiology. In this chapter, we briefly review the growing scientific evidence in regard to neurotransmitter release as a possible mechanism of action of DBS and the potential impact on neuropsychiatric applications.

Cite

CITATION STYLE

APA

Abulseoud, O. A., Knight, E. J., & Lee, K. H. (2012). Neurotransmitter release during deep brain stimulation. In Deep Brain Stimulation: A New Frontier in Psychiatry (pp. 193–204). Springer Berlin Heidelberg. https://doi.org/10.1007/978-3-642-30991-5_18

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free